The Frequency of Fibromyalgia Syndrome and the Quality of Life in Patients with Peritoneal Dialysis


,b>Objective: The aim of this study was to determine the frequency of fibromyalgia (FM) in patients on Peritoneal Dialysis (PD) and to investigate its impact on the quality of life of that population. Methods: A hundred and twenty four patients with end stage renal disease who had undergone PD, and a control group of 54 age and sex-matched healthy volunteers were included to the study. Demographic characteristics including age, sex, disease and dialysis duration were recorded. Fibromyalgia Impact Questionnaire (FIQ) and Nottingham Health Profile (NHP) were also measured. Results: The mean age of the patients (68 female, 56 male) and control subjects (36 female, 18 male) were 43.5 ± 13.4 and 41.2 ± 9.2 years respectively. The prevalence of FM in the PD patients and controls were determined as 9.7% (12 patients) and 11.1% (6 controls) respectively and were found to be similar (p = 0.983). The mean score of sub- groups of NHP except pain and emotion subgroups, were significantly higher in PD patients than in the control group. The mean FIQ levels, the scores of all the subgroups of NHP except the social subgroup were significantly higher in PD patients with FM than in those without FM. Conclusion: In conclusion although the prevalence of FM appears to be similar in PD patients and control subjects, the functional disability is common and quality of life is worse in PD patients with FM than in patients without FM. Detection and treatment of FM may lead to improvement in the quality of life of PD patients with this syndrome.

Share and Cite:

M. Okumus, H. Parpucu, S. Kocaoglu, E. Ceceli, M. Duranay and P. Borman, "The Frequency of Fibromyalgia Syndrome and the Quality of Life in Patients with Peritoneal Dialysis," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 2 No. 4, 2012, pp. 88-93. doi: 10.4236/ojra.2012.24017.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] F. Wolfe, H. A. Smyte, M. B. Yunus, R. M. Bennet, C. Bombardier, D. L. Goldenberg, P. Tugwell, S. M. Campell, M. Abeles, P. Clark, et al., “The American Collage of Rheumatology 1990 Criteria for Classification of Fi- bromyalgia: Report of the Multicentre Criteria Committee,” Arthritis & Rheumatism, Vol. 33, No. 2, 1990, pp. 160-172. doi:10.1002/art.1780330203
[2] S. ?zkurt, A. D?nmez, M. Z. Karagülle, E. Uzuno?lu, M. Turan and N. Erdo?an, “Balneotherapy in Fibromyalgia: A Single Blind Randomized Controlled Clinical Study,” Rheumatology International, Vol. 32, No. 7, 2012, pp. 1949-1954. doi:10.1007/s00296-011-1888-9
[3] F. Wolfe, K. Ross, J. Anderson, I. J. Russel and L. Hebert, “The Prevalence and Charecteristics of Fibromyalgia in the General Population,” Arthritis & Rheumatism, Vol. 38, No. 1, 1995, pp. 19-28. doi:10.1002/art.1780380104
[4] M. Topba?, H. ?ak?rbay and H. Güle?, “The Prevalence of Fibromyalgia in Women Aged 20-64 in Turkey,” Scandinavian Journal of Rheumatology, Vol. 34, No. 2, 2005, pp. 140-144.
[5] L. Neumann and D. Buskila, “Quality of Life and Physical Functioning of Relatives of Fibromyalgia Patients,” Seminars in Arthritis and Rheumatism, Vol. 26, No. 6, 1997, pp. 834-839. doi:10.1016/S0049-0172(97)80027-3
[6] T. Bardin, “Musculoskeletal Manifestations of Chronic Renal Failure. Systemic Disorders with Rheumatic Manifestations,” Current Opinion in Rheumatology, Vol. 15, No. 1, 2003, pp.48-54. doi:10.1097/00002281-200301000-00009
[7] C. I. Couto, J. Natour and A. B. Carvalho, “Fibromyalgia: Its Prevalence and ?mpact on the Quality of Life on a Hemodialyzed Population,” Hemodialysis International, Vol. 12, No. 1, 2008, pp. 66-72. doi:10.1111/j.1542-4758.2008.00243.x
[8] T. E. Yuceturk, A. E. Yucel, H. Yuceturk, H. Kart-Koseoglu, R. Unuvar, F. N. Ozdemir and Z. Akcali, “Fibromyalgia: ?ts Prevalence in Hemodialysis Patients and ?ts Relationships with Clinical and Laboratory Parameters,” Nephrology Dialysis Transplantation, Vol. 20, No. 11, 2005, pp. 2485-2488. doi:10.1093/ndt/gfi028
[9] W. G. Thompson, G. F. Longstreth, D. A. Drossman, K. W. Heaton, E. J. Irvine and S. A. Muller-Lissner, “Functional Bowel Disorders and Functional Abdominal Pain,” Gut, Vol. 45, No. 2, 1999, pp. 1143-1147. doi:10.1136/gut.45.2008.ii43
[10] C. S. Burckhardt, S. R. Clark and R. M. Bennett, “The Fibromyalgia ?mpact Questionnaire: Development and Validation,” The Journal of Rheumatology, Vol. 8, No. 5, 1991, pp. 728-733.
[11] S. Sarmer, S. Ergin and G. Yavuzer, “The Validity and Realibility of the Turkish Version of the Fibromyalgia ?mpact Questionnaire,” Rheumatology International, Vol. 20, No. 1, 2000, pp. 9-12. doi:10.1007/s002960000077
[12] T. D. Wade, “Measures of Handicap and Quality of Life,” In: T. Wade, Ed., Measurement in Neurological Rehabilitation, Oxford University Press, London, 1992, pp. 231- 259.
[13] A. A. Kucukdeveci, S. P. Mckenna, S. Kutlay, Y. Gursel, D. Whalley and T. Arasil, “The Development and Psychometric Assessment of the Turkish Version of the Nottingham Health Profile,” International Journal of Rehabilitation Research, Vol. 23, No. 1, 2000, pp. .31-38.
[14] A. E. Yucel, H. Kart-Koseoglu, I. Isklar, E. Kuruinci, F. N. Ozdemir and H. Arslan, “Bone Mineral Density in Patients on Maintenance Hemodialysis and Effect of Chronic Hepatitis C-Virus Enfection,” Renal Failure, Vol. 26, No. 2, 2004, pp. 159-164. doi:10.1081/JDI-120038501
[15] M. P. Merkus, K. J. Jager, F. W. Dekker, R. J. de Haan, E. W. Boeschoten and R. T. Krediet, “Predictors of Poor Outcome in Chronic Dialysis Patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group,” American Journal of Kidney Diseases, Vol. 35. No. 1, 2000, pp. 69-79. doi:10.1016/S0272-6386(00)70304-0
[16] S. Roizenbatt, H. Moldofsky, A. A. Benedito-Silva and S. Tufik, “Alpha Sleep Characteristic in Fibromyalgia,” Arthritis and Rheumatism, Vol. 44, No. 1, 2001, pp. 222-230.
[17] G. Tridafilopoulus, R. W. Simms and D. L. Goldenderb, “Bowel Dysfunction in Fibromyalgia Syndrome,” Digestive Diseases and Sciences, Vol. 36, No. 1, 1991, pp. 59-64. doi:10.1007/BF01300088
[18] F. Wolfe, M. A. Cathey, S. M. Kleinheksel, S. P. Amos, R. G. Hoffman, D. Y. Young and D. J. Hawley, “Psychological Status in Primary Fibrositis and Fibrositis Associated with Rhematoid Arthritis,” The Journal of Rheumatology, Vol. 11, No. 4, 1984, pp. 500-506.
[19] D. J. Sherrard, G. Herez, Y. Pei, N. A. Maloney, C. Greenwood, A. Manuel, C. Saiphoo, S. S. Fenton and G. V. Segre, “The Spectrum of Bone Disease in End-Stage Renal Failure—An Evolving Disorder,” Kidney International, Vol. 43, No. 2, 1993, pp. 436-442. doi:10.1038/ki.1993.64
[20] D. Wendling and M. Guidet, “Articular and Periarticular Manifestations of Chronic Hemodialysis in the Adult,” Revue du Rhumatisme et des Maladies Ostéo-Articulaires, Vol. 53, No. 12, 1986, pp. 715-721.
[21] K. C. Siamopoulos, M. Dardamanis, D. Kyriaki, M. Pappas, G. Siferopoulos and V. Alevisou, “Pituitary Adrenal Responsivenes to CRF in Chronic Uremic Patients,” Peritoneal Dialysis ?nternational, Vol. 10, No. 2, 1990, pp. 153-156.
[22] E. M. Kaptein, “Thyroid Hormone Metabolism and Thyroid Diseases in Chronic Renal Failure,” Endocrine Re- views, Vol. 17, No. 1, 1996, pp. 45-63. doi:10.1210/edrv-17-1-45
[23] E. G. Lowrie, J. M. Lazarus, A.J. Mocelin, G. L. Bailey, C. L. Hampers, R. E. Wilson and J. P. Merrill, “Survival of Patients Undergoing Chronic Hemodialysis and Renal Transplantation,” The New England Journal of Medicine, Vol. 288. No. 17, 1973, pp. 863-867. doi:10.1056/NEJM197304262881701
[24] R. W. Evans, D. L. Manninen, L. P. Garrison, L. G. Hart, C. R. Blagg, R. A. Gutman, A. R. Hull and E. G. Lowrie, “The Quality of Life Patients with End-Stage Renal Disease,” The New England Journal of Medicine, Vol. 312, No. 9, 1985, pp. 553-559. doi:10.1056/NEJM198502283120905

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.